Literature DB >> 18497947

PTEN expression and methylation status in oral squamous cell carcinoma.

Yoshinori Kurasawa1, Masashi Shiiba, Megumi Nakamura, Kazuaki Fushimi, Takashi Ishigami, Hiroki Bukawa, Hidetaka Yokoe, Katsuhiro Uzawa, Hideki Tanzawa.   

Abstract

PTEN is a tumor suppressor gene located on chromosome10q23.3. In addition to genetic mutations and deletions, the down-regulation of PTEN has been found in various malignant tumors. However, little is known about the profile of PTEN gene in oral carcinomas. In this study, the expression profiles and genetic alterations of PTEN were examined in 113 oral squamous cell carcinoma (OSCC) cases and 9 OSCC-derived cell lines. An immunohistochemical analysis showed statistically significant differences in the immunohistochemical (IHC) scores for PTEN protein in normal tissues and in cancerous regions (P=0.0104), suggesting that PTEN protein expression is down-regulated in OSCC. No significant correlations existed between the down-regulation of PTEN protein expression and the clinicopathological features of the tumor. Reverse transcription-polymerase chain reaction (RT-PCR) analysis showed a lower PTEN mRNA expression in the 9 OSCC-derived cell lines examined, as compared to the normal oral epithelium cells. However, treatment with a demethylating reagent restored PTEN mRNA expression in 4 cell lines. No genetic mutations were detected in these cell lines by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis. The results suggest that epigenetic changes may be related to the down-regulation of PTEN expression. We therefore conclude that PTEN is a crucial molecule in the tumorigenesis of OSCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497947

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  18 in total

1.  PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients.

Authors:  Nisreen Sherif Alyasiri; Syed Jafar Mehdi; M Shabbir Alam; Asgar Ali; Ashish K Mandal; Sunita Gupta; Ishwar Singh; M Moshahid Alam Rizvi
Journal:  J Cancer Res Clin Oncol       Date:  2011-10-28       Impact factor: 4.553

2.  Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.

Authors:  Punnya V Angadi; Rekha Krishnapillai
Journal:  Head Neck Pathol       Date:  2012-03-06

Review 3.  EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy.

Authors:  Christian Freudlsperger; Jeffrey R Burnett; Jay A Friedman; Vishnu R Kannabiran; Zhong Chen; Carter Van Waes
Journal:  Expert Opin Ther Targets       Date:  2010-11-26       Impact factor: 6.902

4.  A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma.

Authors:  Julie E Bauman; Hugo Arias-Pulido; Sang-Joon Lee; M Houman Fekrazad; Hiroyuki Ozawa; Elana Fertig; Jason Howard; Justin Bishop; Hao Wang; Garth T Olson; Michael J Spafford; Dennie V Jones; Christine H Chung
Journal:  Oral Oncol       Date:  2013-02-04       Impact factor: 5.337

5.  Clinicopathological significance of PTEN and bcl2 expressions in oral squamous cell carcinoma.

Authors:  Arshad Rahmani; Mohammad Alzohairy; Ali Yousif Babiker; Moshahid A Rizvi; Husain Gad Elkarimahmad
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

6.  PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck.

Authors:  Miroslaw Snietura; Magdalena Jaworska; Joanna Mlynarczyk-Liszka; Aleksandra Goraj-Zajac; Wojciech Piglowski; Dariusz Lange; Grzegorz Wozniak; Elzbieta Nowara; Rafal Suwinski
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

Review 7.  Epigenetic disregulation in oral cancer.

Authors:  Massimo Mascolo; Maria Siano; Gennaro Ilardi; Daniela Russo; Francesco Merolla; Gaetano De Rosa; Stefania Staibano
Journal:  Int J Mol Sci       Date:  2012-02-21       Impact factor: 6.208

8.  WWP2 is overexpressed in human oral cancer, determining tumor size and poor prognosis in patients: downregulation of WWP2 inhibits the AKT signaling and tumor growth in mice.

Authors:  Chonji Fukumoto; Dai Nakashima; Atsushi Kasamatsu; Motoharu Unozawa; Tomomi Shida-Sakazume; Morihiro Higo; Katsunori Ogawara; Hidetaka Yokoe; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  Oncoscience       Date:  2014-11-28

9.  Immunohistochemical expression of phosphatase and tensin homolog in histologic gradings of oral squamous cell carcinoma.

Authors:  Shiny S R Jasphin; Dinkar Desai; Siddharth Pandit; Nithin M Gonsalves; Preethi B Nayak; Amal Iype
Journal:  Contemp Clin Dent       Date:  2016 Oct-Dec

Review 10.  Current Insights into Oral Cancer Epigenetics.

Authors:  Alexandra Iulia Irimie; Cristina Ciocan; Diana Gulei; Nikolay Mehterov; Atanas G Atanasov; Diana Dudea; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.